BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11883349)

  • 1. A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet.
    Rabl M; Joura EA; Yücel Y; Egarter C
    J Reprod Med; 2002 Feb; 47(2):115-9. PubMed ID: 11883349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing labor with a sustained-release PGE2 vaginal insert. Experience at a community hospital.
    Blair FC; Tassone SA; Pearman CR; St Cyr MB; Rayburn WF
    J Reprod Med; 1998 May; 43(5):408-12. PubMed ID: 9610462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of labour: a comparison between controlled-release dinoprostone vaginal pessary (Cervidil) and dinoprostone intravaginal gel (Prostin E2).
    Kho EM; Sadler L; McCowan L
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):473-7. PubMed ID: 19032662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of two preparations of vaginal prostaglandin for pre-induction cervical ripening.
    Murray HG; Buonocore A; Hawley J
    Obstet Gynecol; 1995 Dec; 86(6):880-5. PubMed ID: 7501332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine rupture with the use of PGE2 vaginal inserts for labor induction in women with previous cesarean sections.
    Taylor DR; Doughty AS; Kaufman H; Yang L; Iannucci TA
    J Reprod Med; 2002 Jul; 47(7):549-54. PubMed ID: 12170531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Labor induction with prostaglandin in post-cesarean section status].
    Schneider KT; Lüftner D; Rath W; Thurmayr GR
    Zentralbl Gynakol; 1994; 116(8):461-7. PubMed ID: 7941815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled release vaginal dinoprostone for the induction of labour].
    Cipriano L; Brosio F; Pacifici E; Berta S; Meloni P; Pace S; Palazzetti PL; Anceschi MM
    Minerva Ginecol; 2003 Aug; 55(4):367-72. PubMed ID: 14581863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of vaginal prostaglandin E2 versus oxytocin for labor induction in term premature rupture of membranes.
    Kunt C; Kanat-Pektas M; Gungor AN; Kurt RK; Ozat M; Gulerman C; Gungor T; Mollamahmutoglu L
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):57-61. PubMed ID: 20466294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of labor with prostaglandin E2 in women with previous cesarean section and unfavorable cervix.
    Yogev Y; Ben-Haroush A; Lahav E; Horowitz E; Hod M; Kaplan B
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):173-6. PubMed ID: 15358459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two preparations of dinoprostone for pre-induction of labour in nulliparous women with very unfavourable cervical condition: a randomised clinical trial.
    Facchinetti F; Venturini P; Verocchi G; Volpe A
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):189-93. PubMed ID: 15808378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term.
    Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M
    J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of uterine activity. Using oxytocin after intracervical PGE2.
    Coleman FH; Rayburn WF; Burks LS; Farmer KC; Larson JD; Turnbull GL
    J Reprod Med; 1997 Jan; 42(1):44-8. PubMed ID: 9018645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of spontaneous labor with induced vaginal tablets prostaglandin E2 in grand multiparae.
    Sobande AA; Al-Bar HM; Archibong EI
    Saudi Med J; 2001 Aug; 22(8):698-701. PubMed ID: 11573116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of delivery in pregnancies with premature rupture of membranes at or before term following induction of labor with vaginal prostaglandin E2.
    Ben-Haroush A; Yogev Y; Glickman H; Bar J; Kaplan B; Hod M
    Am J Perinatol; 2004 Jul; 21(5):263-8. PubMed ID: 15232758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial.
    Wing DA;
    Obstet Gynecol; 2008 Oct; 112(4):801-12. PubMed ID: 18827122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicated labor induction with vaginal prostaglandin E2 increases the risk of cesarean section even in multiparous women with no previous cesarean section.
    Ben-Haroush A; Yogev Y; Bar J; Glickman H; Kaplan B; Hod M
    J Perinat Med; 2004; 32(1):31-6. PubMed ID: 15008383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of labor using high-dose or low-dose prostaglandin vaginal pessaries.
    Hunter IW; Cato E; Ritchie JW
    Obstet Gynecol; 1984 Mar; 63(3):418-20. PubMed ID: 6366660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of single prostaglandin E2 vaginal tablet with prostaglandin E2 vaginal pessaries for induction of labor at term.
    el-Mardi AA; el-Qarmalawi MA; Siddik M; el-Haroni A; Ammar A; Madkoor SA
    Int J Gynaecol Obstet; 1991 Jul; 35(3):221-4. PubMed ID: 1677625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.